HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abatacept in spondyloarthritis refractory to tumour necrosis factor alpha inhibition.

AuthorsI Olivieri, S D'Angelo, G A Mennillo, G Pistone, E Scarano, A Padula
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 68 Issue 1 Pg. 151-2 (Jan 2009) ISSN: 1468-2060 [Electronic] England
PMID19088259 (Publication Type: Case Reports, Letter)
Chemical References
  • Immunoconjugates
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Abatacept
Topics
  • Abatacept
  • Female
  • Humans
  • Immunoconjugates (therapeutic use)
  • Immunosuppressive Agents (therapeutic use)
  • Spondylarthritis (drug therapy, immunology)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: